SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " lini " 2,979 found 🔀 AI-powered Shuffle
Biohaven Reports Recent Business Developments and Second Quarter 2026 Financial Results
First extracellular protein degraders in the clinic demonstrate rapid and robust pharmacodynamic effects and compelling safety in nearly 200 individuals dosed,...
New AI for Health Initiative Connects Computer Science and Medicine
Led by the UC Davis Department of Computer Science, the AI for Health Initiative will connect researchers and clinicians across disciplines to advance responsible AI use in medicine, support student training and strengthen partnerships with UC Davis Health.
New AI for Health Initiative Connects Computer Science and Medicine
Led by the UC Davis Department of Computer Science, the AI for Health Initiative will connect researchers and clinicians across disciplines to advance responsible AI use in medicine, support student training and strengthen partnerships with UC Davis Health.
Pioneer cardiologist Robert Frye remembered for kindness, ‘unwavering focus’ on his patients
Robert L. Frye, MD, spent more than 60 years with Mayo Clinic. He was also a former president of the American College of Cardiology.
Vermont Psychiatric Care Hospital cuts staff and beds despite pushback
The Department of Mental Health says the cuts are due to declining census, though demand for psychiatric care is high in Vermont.
Thousands of Endangered Species Condoms Distributed to Health Clinics, Mutual Aid Groups After Federal Funding Cuts
TUCSON, Ariz.— The Center for Biological Diversity has distributed more than 20,000 free Endangered Species Condoms so far this year to health clinics, mutual aid groups and social service organizations in the wake of federal funding cuts, including recent cuts to the Teen Pregnancy Prevention Program.
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
AbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women’s health market. The phase 2 clinical trial compared ABCL635, an antibody targeting NK3R, to placebo in patients with hot flashes caused by menopause. Investigators enrolled 92 postmenopausal women experiencing a mean of about 10 moderate or severe hot flashes per day. By Week 4, the number of moderate or severe hot flashes had fallen by a mean of 8.8 on ABCL635 and by 3.5 on placebo. That statistically significant, placebo-adjusted reduction of 5.3 hit the trial’s primary endpoint. The level of efficacy also cleared the bar set by existing drugs. While cross-trial comparisons can be misleading, AbCellera CEO Carl Hansen, Ph.D., had seen enough to start hyping the program. “We now view ABCL635 as a potential best-in-class non-hormonal therapy with strong differentiation against approved NK3R competitors across all important dimensions, including efficacy, safety, dosing and convenience,” Hansen said on a Monday morning conference call with investors to discuss the data. “We believe ABCL635 is now a highly de-risked program.” Last week, Hansen used AbCellera’s earnings call to set expectations for readout, with the CEO defining success as a clean safety profile and efficacy comparable to the two approved small molecules. The data vaulted over that bar. Astellas linked (PDF) one of the small molecules, Veozah, to placebo-adjusted reductions in hot flash frequency of 2.1 and 2.6 at Week 4 of its two phase 3 trials. Bayer reported (PDF) placebo-adjusted reductions of 3.04 and 3.29 at Week 4 of pivotal studies for its small molecule, Lynkuet. At 5.3, the placebo-adjusted reduction in AbCellera’s trial comfortably cleared the standard set by the incumbents. Veozah and Lynkuet came to market based on evidence of their ability to reduce the frequency and severity of hot flashes. AbCellera’s phase 2 study covered both endpoints, with the Canadian biotech reporting a mean reduction in severity of 1.4 points at Week 4 on ABCL635, compared to 0.3 points for placebo. Again, the placebo-adjusted result compares favorably to data on Veozah and Lynkuet. Analysts shared Hansen’s enthusiasm for the data. The phase 2 results “firmly validate ABCL635 as a potentially best-in-class treatment,” BMO Capital Markets analysts said in a note to investors Monday. ABCL635’s apparent efficacy edge “is likely attributable to the higher dosing/target engagement the asset is able to reach vs. the oral agents due to its wider therapeutic index,” the analysts added. The analysts, who model $2.3 billion in unadjusted peak sales for ABCL635, flagged the safety profile as another positive of the phase 2 readout. While Veozah carries a boxed warning for liver damage, nobody on ABCL635 in the phase 2 trial had elevated liver enzymes or bilirubin values. If replicated in phase 3, the lack of a liver signal could allow approval without the monitoring requirements imposed on Veozah. Investors appeared equally enthused, sending AbCellera's stock up 32% to $9.21 in premarket trading Monday from a Friday closing price of $6.93. Next, AbCellera will collect the Week 12 data and talk to its advisors about further development. The results open up “a wide variety of possibilities of how we might take this forward into phase 3 studies to truly maximize the value of the asset and make sure that ABCL635 is able to demonstrate its differentiation potential,” Sarah Noonberg, M.D., Ph.D., AbCellera’s chief medical officer, told investors.
With Medicaid cuts ahead, Louisiana’s rural health providers battle over payments
As the pool of Medicaid patients shrinks and Medicaid funding runs up against new limits, independently owned health clinics will receive a much larger share of what’s available once their new reimbursement rates go into place.
Cynopsis 8/10/2026: The Media And Entertainment Industry Is Creating Jobs
Monday, August 10, 2026 Happy Monday, readers! Today’s newsletter includes: A Hollywood-Shaped Silver Lining In July’s Jobs Report So Much
Nature Medicine Just Published the AI Mental Health Audit Framework the FDA Hasn’t Written Yet
Nature Medicine's clinically validated AI chatbot audit framework arrives as FDA still lacks generative AI mental health approval standards—here's what trial…
Exmoor market health hub helping farmers discover hidden conditions
Exmoor Rural Health Hub runs screening clinics twice a month at Cutcombe Market in Wheddon Cross.
Bronchiectasis: How To Manage Your Mental Health and Stay Connected
If daily symptoms and flares take their toll on your mental health, you’re not alone. A pulmonologist shares how to cope and manage.
Black Book: Australia's 2027 Health IT Market Shifts From Pilots to Proof
Post-HIC 2026, provider study finds interoperability, clinical cyber continuity and statewide EHR execution will dominate the next buying cycle NORTH SYDNEY, AU / ACCESS Newswire / August 9, 2026 / Black Book Research today announced the publication ...
Exclusive: Spotify’s new ‘skip’ button could end the podcast business as we know it
The Swedish streaming giant cast the move as streamlining a feature that already exists, the Spotify app’s 15-second skip button.
At colleges, the AI boom means everyone wants to dabble in computer science
Hiring for entry-level software developers has slowed, and college enrollment in computer science is declining. However, interest in artificial intelligence is growing among students from non-tech majors. Schools like VCU
California Prop 44 would force health clinics to spend 90% on patient care
A measure aimed at changing how community health clinics spend taxpayer dollars is heading to the ballot box this November. Voters will decide the fate of Proposition 44. Supporters say it will increase accountability, but opponents warn it could threaten services patients rely on.
Omada Health (OMDA) Could Be 4% Undervalued As Record Earnings Reset The Debate
Omada Health (OMDA) drew investor attention on 6 August 2026 after reporting record second quarter results, raising full year 2026 guidance, and outlining a planned CEO transition effective 1 January 2027. See our latest analysis for Omada Health. At a latest share price of $23.67, Omada Health has seen a sharp shift in sentiment, with a 1 day share price return of 21.14% and 7 day share price return of 19.30% around the earnings beat and CEO succession news. That sits within a stronger...
Remote Area Medical brings free health clinic to Bennington
Remote Area Medical is holding a free two-day dental and vision clinic at Mount Anthony Union Middle School in Bennington — the organization’s fourth visit to the area.
Oscar Health Q2 Earnings Call Highlights
Oscar Health (NYSE:OSCR) reported record profitability for the first half of 2026 and raised its full-year operating outlook, citing membership growth, disciplined pricing, favorable utilization trends and lower administrative expense ratios. Chief Executive Officer Mark Bertolini said the company
Austin Public Health offering 3 vaccine clinics during August
Austin Public Health will hold vaccine clinics in August for National Immunization Awareness Month.
David Sinclair Launches Lifespan Media Platform for Longevity Science
David Sinclair launches Lifespan media platform to improve public understanding of longevity science research and clinical trials.
Deputies shoot armed person ‘experiencing a mental health episode,’ Riverside County Sheriff’s Office says
Deputies shot an armed person “experiencing a mental health episode” in Moreno Valley Friday, according to the Riverside County Sheriff’s Office. Sheriff’s deputies and a clinical therapist from th…
St. Petersburg psychologist shares advice for long-term health improvements
Clinical psychologist Dr. Elizabeth Bendick in St. Petersburg emphasizes that improving overall health begins with establishing consistent daily habits rather than overwhelming life overhauls.
Metro Health hosts back-to-school vaccine clinic for Immunization Awareness Month
San Antonio Metro Health hosts a back-to-school immunization event Aug. 9, 9 a.m. to 1 p.m. at Wheatley Heights Sports Complex. No appointment needed. Vaccines via state programs, plus family resources. Supplies limited.
Tashiba Williams: How Mobile Wound Care Is Expanding Healthcare Access
As a family nurse practitioner and the founder of ADA Family Health Clinic, a mobile wound care and primary care practice serving patients across Texas and Louisiana, Williams represents healthcare professionals whose clinical experience may contribute to leadership and care-delivery discussions.
How Cohere Health digitizes clinical policies using Amazon Bedrock AgentCore
In this post, you learn how Cohere Health built a multi-tenant agentic architecture on AgentCore using AgentCore Runtime’s secure MicroVM isolation, unified tool access through AgentCore Gateway, AgentCore Memory, and the Agent Skills open standard to rapidly scale policy digitization capabilities, while preserving transparency, version control, and human oversight.
Essentia Health-Duluth Clinic welcomes family medicine specialist Dr. Nicholas Woessner
Dr. Nicholas Woessner, a doctor of osteopathic medicine specializing family medicine, is thrilled to join the Essentia Health-Duluth Clinic.
Seattle-area community clinics to lose family medicine residents
A Providence Swedish training program plans to cut ties with three community clinics that have historically served lower-income patients of color.
A third clinic settles with DOJ over trans care
Anthony Fauci held in contempt, crackdowns on the organ donor network, and more health news from Morning Rounds
France’s Cinema Rebound Can’t Escape Politics: Paris Edition
Viewership is up, but declining revenue has made the sector a target
Health clinics provided to Colorado students in Cherry Creek Schools before return to class
Health clinics provided to Cherry Creek Schools students before return to classes
A clinically validated framework for auditing AI chatbot behavior in mental health interactions
Nature Medicine - Across 810 conversations, an evaluation framework finds that AI chatbots often amplify simulated users’ psychological vulnerabilities, revealing persistent safety risks in...
New heart drug targeting inflammation falls short in clinical trial
The ZEUS trial fell short, but Novo Nordisk still has high hopes for HERMES and ARTEMIS.
Texas rural clinics turn to telehealth
Clinics with better internet connections are now offering telehealth services to patients who can’t do it from their homes.
AHF • ‘We the People’ Coalition Merges Faith & Politics to Engage Black Voters -- L.A. Gospel Concert & Panel, Sat., Aug. 8th
AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS healthcare organization, currently provides medical care and services to more than 1.75 million clients in 45 countries. With more than 7,000 employees worldwide, AHF now has treatment clinics and other operations in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.
VA accelerates electronic health record rollout
After years of delays, the Department of Veterans Affairs says its federal electronic health record (EHR) program is now firmly back on track. VA Secretary Douglas Collins has accelerated the program with a renewed goal: full deployment across all VA medical centers by 2031. A major governance overhaul, replacing multiple competing councils with a single decision-making body, has cut through bureaucratic delays and allowed the VA to move faster and more consistently. Deputy Secretary Paul Lawrence has taken a hands-on role, including visiting deployment sites and holding daily meetings with Oracle Health to ensure front-line clinicians have what they need. Here’s how the rollout is going, according to the VA: The federal EHR has only experienced four outages since December 2025. The system has gone nearly two consecutive years without a major incident. It is currently live at six sites, supporting care for over 188,000 veterans. The system creates a lifelong medical record, integrating data across the VA, the Department of Defense and private community providers. With the first new deployments underway and four Michigan medical centers already live in 2026, the VA is entering its first true expansion phase since the program’s reset. Officials say the system’s improved stability, streamlined governance and standardized national workflows have cleared the obstacles that once stalled progress. With 13 sites scheduled for deployment in 2026 and a market‑based rollout strategy guiding future waves, the department believes it’s finally positioned to move at scale toward a modern, fully interoperable EHR, advancing steadily toward its goal of reaching every VA medical center in five years.
US Stand Up for Science movement expands to Europe
A grassroots movement by scientists in the US pushing back against threats to academic freedom is setting up a Swiss outpost to take the movement global. Stand Up for Science started in February 2025 to protest against politically-motivated grant cancellations by the Trump administration. Since then, it has organised numerous rallies by scientists and turned into a broader campaigning organisation, supporting “pro-science” political candidates and attempting to impeach Robert F. Kennedy Jr, the health and human services secretary the group accuses of advancing “quack” science. Now, Stand Up for Science is establishing a Swiss office to take some of its campaigning beyond the US, and its leader is urging European academics to organise similar pro-science groups in case they face similar threats in Europe. There will likely be “spillover” to Europe from what the Trump administration is attempting in the US, said Colette Delawalla, chief executive of Stand Up for Science, who last month returned from a tour of Europe. “Are we going to see a Trump-style scientific [. . .] take over in the same way?” she asked.Delawalla, who is doing a PhD in clinical psychology, said she was driven to help found the organisation after the Trump administration started cancelling health research grants in politically taboo topics, such as transgender people, diversity and HIV, in early 2025. Since then, the administration has introduced several other measures that infringe academic and institutional autonomy.It threatened to cut Harvard University’s federal funding unless the university accepted a “critical mass” of new faculty and students to create “viewpoint diversity.” And this year, it proposed explosive new rules that would allow political appointees at research funders to screen grants to make sure they “advance the president's policy priorities.”US scientists have been at times stunned by the volume of announcements, and the country’s researchers were relatively unprepared. “We sit in front of the fire hose every day,” said Delawalla. For this reason, European scientists need to prepare now for similar assaults. “If you've got a little bit of extra time to start thinking through, and making those preparations and building community and solidarity,” then European researchers will “start five steps ahead of where we were.” She plans to return to Paris in September to share experiences with concerned French academics. Is Le Pen the same?During her European tour, Delawalla said that French academics were beginning to worry about a National Rally (RN) victory in presidential elections next year. She said there were “chilling similarities” between Trump and Marine Le Pen, the RN’s likely candidate. However, so far, the RN hasn’t proposed anything nearly as radical as the Trump administration has carried out. Its current manifesto is all but silent on university and research policy. Le Pen’s 2022 manifesto bemoaned a lack of French R&D spending, including in fundamental research, and promised to modernise labs and strip away grant bureaucracy. The party’s 2024 European election manifesto explicitly supported the Erasmus+ student exchange programme, scientific exchange and joint European technology projects. However, a Le Pen victory next year could see France drastically cut its contribution to the EU, which would hit the budget for science and innovation. Meanwhile, more restrictive immigration policies could hit university recruitment of faculty and students. Climate science denial?As heatwaves and wildfires have ravaged France, the RN has sought to distance itself from previous comments casting doubt on climate science.In the UK, the radical-right party Reform UK, now second in the polls, denied climate research in a draft of its 2024 election manifesto, but its leader, Nigel Farage, then appeared to quietly U-turn and said he was “not arguing the science.” By contrast, Trump has repeatedly and explicitly denied climate change science, in 2025 calling it “the greatest con job.” Like the RN, Reform UK has been light on research and university policy. However, it did say in its 2024 manifesto that universities should suffer “heavy financial penalties” for allowing “political bias or cancel culture” on campus, building on laws brought in by a previous Conservative government. Ahead of September state elections in Saxony-Anhalt in Germany, the poll-leading Alternative for Germany has proposed abolishing gender studies and postcolonial studies, and promised money for “critical” climate research and studies of Islam. Starts with rhetoricEven if European radical right parties aren’t currently planning the draconian policy measures of the Trump administration, Delawalla said that academics should not be complacent, and fight even small funding restrictions or anti-science talk from the start. “It starts off with sowing distrust about institutions,” she said. “It starts off with these small things, and then all of a sudden it's there.” There are other, more established science and university advocacy groups in the US aside from Stand Up for Science. But the group stands out because of Delawalla’s refusal to attempt to appear politically bipartisan or conciliatory. “I firmly believe that the US is experiencing fascism,” she said. “We’re not trying to win over the super Maga people,” she said, “and we never have been.” The lesson of the US is that even if universities or other institutions capitulate to government demands, this doesn’t save them from cuts and restrictions. “It doesn’t matter what people do,” she said. Global “pseudoscience”Another aim of Stand Up for Science’s push into Europe is to better coordinate a campaign to protect people in poorer countries from what the group describes as “pseudoscientific exploitation,” trials outside the US used to build a case against things like vaccines. Earlier this year, the group sent an investigator to Guinea-Bissau to investigate a controversial, Danish-run Hepatitis B vaccine project funded by the US Centers for Disease Control and Prevention.The study would have withheld a proven vaccine from newborns, Stand Up for Science argued in a briefing it presented to Congress, risking their health. Significantly, the research group based in Guinea-Bissau, known as Bandim, focuses on the “non-specific effects” of vaccines: impacts on health beyond preventing the target disease. Related articlesEuropean researchers sound the alarm that Trump rule changes will hit cooperationData corner: which fields of health science is the US curbing? The US ‘golden age’ science strategy: what Europeans need to know The suspicion is that the study was funded as part of an attempt to shop around for results that could help build a case against vaccines in the US, said Delawalla. “This is just code for vaccines cause autism,” she said.Bandim has put out a rebuttal of Stand Up for Science’s criticisms, arguing its work has uncovered a number of vaccine side effects, both positive and negative, which need to be taken into account in public health. However, Congressional Democrats took up the Stand Up for Science cause, and in February, Guinea-Bissau said it had permanently halted the study. WatchdogBut for Delawalla, this is not the end of the fight. Kennedy has made a number of health claims that scientists think lack evidence, such as the idea that seed oils cause inflammation, for example. Delawalla worries that more studies could be launched in poorer countries to fish around for evidence to support this agenda. Stand Up for Science is talking to African science organisations to create a kind of “watchdog” to scrutinise any further trials. “Outsourcing the investigation to some of the most vulnerable children in the world who are desperate [. . .] is fundamentally wrong,” she said.
Isabella Rossellini Explains Why She Lives in US Despite Bad Politics
The Italian-American actress, model and filmmaker also explained why "I don’t like TV shows" after being honored with the Swiss fest's Excellence Award the night before.
Newcastle plot £85m Nmecha bid as Guimaraes replacement
Newcastle United are lining up a club-record bid for Borussia Dortmund’s Felix Nmecha as the club seek a replacement for Bruno Guimaraes.Guimaraes is closing in on a £75m transfer to Arsenal after ...
Experts share MRI efficiency strategies that could raise revenue by upward of 60%
Workflow redesigns have the potential to improve MRI throughput by 20%, while AI-based protocol optimization could boost efficiencies by another 35%, experts write in Clinical Imaging.
How much and why premiums are going up for small businesses in 2027 - Peterson-KFF Health System Tracker
Each year, health insurers submit rate filings to state regulators outlining their expectations for the coming year and proposing premium changes for Affordable Care Act (ACA)-compliant plans. This analysis examines filings in the small group market, which covers plans offered to small businesses (generally with 50 or fewer full-time equivalent employees). Some of this coverage is […]
Clopidogrel monotherapy bests aspirin when patients with diabetes undergo PCI
After an initial period of DAPT, what's the best next step? A new analysis reviewed data from the SMART-CHOICE 3 clinical trial.
Federal regulators invite industry, researchers, and lobbyists to closed-door meetings on clinical AI
Federal health officials invited tech companies and lobbyists to closed-door meetings as they seek to boost adoption of clinical AI.
New Golisano Children’s Mobile Health Clinic to Serve Communities Throughout Rochester
University of Rochester Medicine Golisano Children's launched its Pediatric Mobile Clinic Initiative with a ribbon-cutting ceremony attended by community leaders, healthcare providers, donors, and Rochester leaders.
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Swallowing faecal capsules reduces peanut allergy in six adults
Altering the gut microbiomes of people with peanut allergy using faeces donated from an allergy-free individual improved their peanut tolerance in a clinical trial
Silver Bay clinic closure draws concerns over rural health care access
Aspirus Lake View’s Silver Bay Clinic will close Dec. 31. The health care provider announced that future clinic visits, laboratory services and radiology will relocate to the Lake View Two Harbors Clinic. The Minnesota Department of Health held a hearing July 28 to provide a forum for community members to discuss the change in services....
Procter & Gamble acquires Thorne for $3.8bn in bet on science-backed supplement growth
The deal, expected to close in Q4 2026, brings Thorne's clinically validated, practitioner-trusted supplement portfolio into P&G's consumer health stable — signalling mainstream consumer goods giants' accelerating move into premium VMS
CVS Health enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
CVS Health® today announced a revamp of its weight management program, making it easier for eligible adults to access clinical care, navigate medication costs and get ongoing support for GLP-1 therapy.
LLMs better than docs at providing clinical context for imaging orders
The inclusion of clinical indication is standard for imaging requisitions, but the information provided is often vague and leaves out useful context that could help radiologists.
Kansas just affirmed that abortion politics still matter - Live Updates
Voters rejected a measure that was yet another ploy to restrict the right to abortion in the state.
Reds owner Bob Castellini crashes Francona session, delivers message
Was it simply a wrong turn or a vote of confidence for the Cincinnati Reds manager? It looked like it was probably both.
The Beauty Of Settled Science
Commenters convinced me I made a subtle mis-step in my framing of Psychology Research Is Mostly Fine. My framing emphasized that social priming studies had failed to replicate, but that many other subfields of psychology hadn’t. This naturally led commenters to point to failed replications in other subfields. Although none of these were as bad as social priming, few or none were entirely problem-free. Instead of emphasizing the difference between social priming and other subfields, I should have emphasized the difference between settled science and novel research. Here are some of my favorite psychology findings: The brain is sculpted by reinforcement learning, and a key driver of this learning is a prediction-error-based algorithm located in the nucleus accumbens and implemented through dopamine. Psychedelic drugs exert their effects through 5-HT2A receptors, pointing to a role for these receptors in some sort of construct like the balance between priors and new evidence. Certain cognitive functions are localized to certain brain areas (for example, impulse control to the frontal lobes; linguistic structure to Broca’s area, linguistic meaning to Wernicke’s area. But injure one of these areas, or render a certain function useless (eg a blind person having no more use for their visual cortex), and these mappings can gradually shift - suggesting that neurons are general-purpose compute whose specialization is a contingent fact about convenience and efficiency rather than a necessity. Most personality traits and general capabilities are about 50% genetic and 50% random, with little role for family environment or childhood history, with a few notable exceptions like partisan preference. Recent research complicates this story, but the further you go from this basic picture, the gnarlier the chains of indirect causation you require. Neurons fire together in “brain waves”, whose exact frequency corresponds with the character of consciousness; These divide neurons into natural subpopulations and linked graphs. The gamma rhythm corresponds surprisingly well to items in conscious awareness. GABA receptors seem to be involved in something like relaxation. By hitting different GABA receptors in different ways, you can modulate the exact type of relaxation you produce. Hitting GABA-A directly is too powerful and can cause dangerous levels of sedation, but allosteric modulation of GABA is an incredibly fruitful strategy that underlies drugs from benzos to barbituates to alcohol. If you know your GABA-A subunits, you can target specific subtypes of relaxation; for example, Ambien hits GABA-A1 and induces sleep. Memory divides somewhat fuzzily into bins of immediate-sensory, short-term, and long-term, with separate retrieval and storage functions, and separate systems for declarative vs. procedural learning. These can be harmed selectively, usually by hippocampal injury, so that some patients can remember their life stories but not form new long-term memories, or learn new skills like bike-riding but not new facts. The exact substrate of memory is unclear but seems to involve new synaptic connections between neurons in at least some way. The ability of modern psychology and psychiatry to treat mental illness is real but limited. SSRIs work for half or slightly fewer than half of patients; antipsychotics work with extreme side effects; benzodiazpines work but produce addiction and tolerance in many (not all) people. Most supplements are stuck in Poor Quality Study Replication Crisis Hell, but melatonin and l-theanine stand out as especially promising. Psychotherapy works with moderate effect size, but (with a few exceptions) seems to be more about the relationship with the provider than the details of the therapy itself. Mental hospitalization can sometimes defuse immediate crises but work less well than mental hospitals would like, with some studies showing overall negative effects. Schizophrenia is mostly genetic, but risk also increases with prenatal infection (especially rubella) and obstetric complications; there is suggestive evidence for roles of social stress and drug use (with psychedelics and marijuana making things worse, and nicotine if anything making things better). Bipolar and schizophrenia are so closely linked on a pathophysiological level that it seems like they might be the same disease; on the clinical level, they do seem to follow two separate courses/prognoses but can sometimes surprise clinicians by eg someone who seemed condemned to permanent schizophrenia unexpectedly recovering. The brain’s native reinforcement learning algorithms cash out in the phenomena of classical and operant conditioning; different reinforcement schedules reinforce at different levels, which can be exploited by bad actors to make especially compelling products (eg slot machines). None of these are immune to doubt. A few are speculative; one or two are genuinely unorthodox. But they’re all a step above one p = 0.049 paper that might not replicate. If they get overturned, they’ll be overturned by the same sort of genuine scientific shift that replaced Ptolemy with Copernicus or Lamarck with Darwin, not some sort of sordid discovery about someone entering random numbers into a spreadsheet. In 2008, Eliezer Yudkowsky wrote about The Beauty Of Settled Science: If you only care about scientific issues that are controversial, you will end up with a head stuffed full of garbage. The media thinks that only the cutting edge of science is worth reporting on. How often do you see headlines like “General Relativity still governing planetary orbits” or “Phlogiston theory remains false”? So, by the time anything is solid science, it is no longer a breaking headline. “Newsworthy” science is often based on the thinnest of evidence and wrong half the time—if it were not on the uttermost fringes of the scientific frontier, it would not be breaking news. Scientific controversies are problems so difficult that even people who’ve spent years mastering the field can still fool themselves. That’s what makes for the heated arguments that attract all the media attention. Worse, if you aren’t in the field and part of the game, controversies aren’t even fun. Don’t be embarrassed to read elementary science textbooks, either. If you want to pretend to be sophisticated, go find a play to sneer at. If you just want to have fun, remember that simplicity is at the core of scientific beauty [...] A steady diet of science news is bad for you: You are what you eat, and if you eat only science reporting on fluid situations, without a solid textbook now and then, your brain will turn to liquid. Psychology isn’t centrally the new paper in Annals Of Recently-Breaking News saying that an n=5 study showing that large portion sizes increase support for terrorism. Psychology is centrally ideas like brain waves, GABA receptors, reinforcement learning, twin studies, and connectionism. People who think differently are worrying too much about BREAKING NEWS!!!, and should stop. The key distinction isn’t “recent research in social psychology” vs. “recent research in cognitive/bio/behavioral psychology”, as my essay last week unfortunately implied. It’s recent research in general vs. the deposit of settled science, battle-tested hypotheses, and carefully-earmarked speculation. And part of the reason social priming in particular was such a disaster was that it defied that heuristic, building itself up over hundreds of studies until it approached or even entered the pantheon of settled science - before collapsing (5-HTTLPR was also sort of like this). This isn’t a claim that settled science is always right - Freud was “settled science” for a long time - just that there’s an intuitive distinction between the level of credence you should have in the existence of power posing vs. the existence of Broca’s Area. (I compounded this error by calling the last post “Psychology Research Is Mostly Fine”, which suggested I was talking about the new research rather than the settled science. I actually meant to distinguish between research-psychology-the-field vs. clinical-psychology-aka-therapy, but this framing unintentionally pushed against the point I wanted to make) Some commenters on the previous article understood this point, but challenged its weight. It’s very cool, they said, to know how many neurons are in which brain lobe, but the main way that Psychology affected their lives was through bad clickbait studies used to buttress dumb policies; some p = 0.049 study says that exposure to microaggressions makes minorities’ brains shrivel into raisins, and now their company has to implement punitive DEI or be sued for hazardous work conditions. I won’t dispute this as an accurate description of how the sausage gets made, but it’s worth examining the trains of thought that connect this observation to a campaign against psychology in general: The dumb woke psychology was wrong and bad, and I don’t have good heuristics for distinguishing dumb woke psychology from other psychology, so I’m going to assume it’s all wrong and bad. The dumb woke psychology was wrong and bad; it seems useful to punish/discredit psychology as a whole to assist my campaign against it, so for propaganda purposes I will try to discredit psychology as a whole. To people in the first camp, my response is: come on, your heuristics aren’t that bad. “Microaggressions makes minorities’ brains shrivel up like raisins” is in the woke category; “the hippocampal theta rhythm seems to be associated with both memory and pathfinding, suggesting an unexpected yet surprisingly compelling relationship between the two” is in the not-woke category, don’t play dumb here. To people in the second camp, my response is: deliberately exaggerated propaganda campaigns are bad and this is a confession, not an excuse. Inability to view science through anything but a political lens was what got us into this problem; doubling down on it is a temporary solution but a recipe for permanent disaster. If you pronounce entire fields of science to be acceptable collateral damage in your campaign against bad political actors, you will alienate not just scientists but patients, clinicians, and general lovers of truth. Instead, you can say the thing you mean - that woke partisans shouldn’t try to occupy and exploit the otherwise-noble science of psychology for their own political gain - and wage the same campaign with a halo rather than a comic-book-villain goatee. From the font of oracular wisdom that is Weird Sun Twitter: [ Vessel Of Spirit@VesselOfSpirit i love you all conditionally but i love the good part of you unconditionally. even if it becomes a very small part 2:11 AM · Jan 22, 2015 1 Reply · 5 Reposts · 29 Likes ](https://x.com/VesselOfSpirit/status/558084551772471298) This is how I feel about psychology1, too, but with a touch more optimism. The good part of psychology is enormous, a hoard of endless treasures. You just have to look past the headlines! 1 To play devil’s advocate - should one always be so magnamious? Astrology? Phrenology? These seem different in that their entire orientation was flawed from the start; they didn’t simply fail to find the correct constellation-personality connections, the whole project of searching for connections between constellations and personality was doomed from the start. More difficult might be asking the same question about education research, which is notoriously bad. I don’t know enough about education research to know if there’s some settled science of correct and enlightening results lurking in the background beyond the day-to-day froth of poorly-conducted and politically-motivated studies. I think if it’s 90% bad, 10% good, it’s correct to call it bad as a compact way of communicating a useful truth; I think psychology is better than that, but admit it’s a tough judgment call.
Plini Shares 5 Of His Wildest & Most Wholesome Tour Memories
Fidji Simo had to leave OpenAI. But she’s still building a business that could find cures to chronic diseases that affect women like her
ChronicleBio is using AI to improve clinical trials and find cures for diseases like POTS.
'We are not Superman': How Boston is pushing to improve men's health
To reach more male patients, the Whittier Street Health Center in Boston runs a men’s health clinic and hosts an annual summit to focus attention on men’s health issues. In June, Boston health leaders announced plans to invest $1 million a year to help close the gap in Black men’s life expectancy.
CA is dismantling its healthcare system
In a new documentary, CalMatters goes inside a Los Angeles clinic to examine how Californians are being forced to choose between medicine and food.
Robert Wood Johnson University Hospital, Cooperman Barnabas Medical Center Named Best Hospitals by U.S. News & World Report
RWJBarnabas Health hospitals are once again recognized for delivering exceptional patient care and outstanding clinical outcomes in the 2026-2027 U.S. News & World Report Best Hospitals edition for adult healthcare services.
Capricor’s Duchenne AdCom Didn’t Fail on Science. It Failed on Statistics.
FDA's CTGTAC voted 9-3 against Capricor's deramiocel on July 30, 2026. The science wasn't the problem. The statistical methodology was — and the FDA let it get…
Spirit's collapse hits businesses in Detroit Metro's Evans Terminal
Spirit Airlines' exit from Detroit Metro Airport has left vendors in the Evans Terminal facing empty gates, declining sales, uncertainty.
AI use surging for mental health help among young people
Survey researcher says popularity may help fill gap between rising national problem, shortage of clinicians — provided counsel is sound.
Methodist Healthcare acquires 18 Texas MedClinic locations in San Antonio
Methodist Healthcare announced the acquisition of 18 Texas MedClinic urgent care facilities in San Antonio on Monday.
Future Warriors clinics connect Wilton youth to sports - Monadnock Ledger-Transcript
Wilton Junior Athletic Association hosted Future Warriors Summer Clinics for 3rd to 6th graders to build skills and teamwork.
Burnout wrecked my health. I lost 125 pounds getting it back.
Mary Roberts says recovering from burnout helped her lose weight reverse her declining health, and regain the confidence to launch her own consultancy.
As computer science enrollments drop, artificial intelligence classes fill up
Hiring for entry-level software developers has slowed, and college enrollment in computer science is declining
Clinical Trials Aren’t the Only Way to Know if Flu Shots Work
With a bit of creativity, evidence can be drawn from data we already have in the form of natural experiments, write Christopher M. Worsham and Anupam B. Jena.
School Smartphone Bans Show No Effect on Youth Mental Health
Following a decade of declining youth mental health, many states have attempted to limit children’s access to social media and the internet by banning smartphones in schools. In new research, Henry Saffer finds no evidence that in-school smartphone bans have any effect on the screentime or mental well-being of young Americans.
AI Identifies Previously Unrecognized Health Insights in Routine Sleep Studies
Interdisciplinary research team develops foundation model that identifies patient groups with markedly different long-term health risks
Are AI scribes useful tools in medical education, or a crutch that imperils learning?
Educators want future physicians to be fluent in AI scribes, but they worry what off-loading clinical notes to AI could do to learning.
At colleges, the AI boom means everyone wants to dabble in computer science
Hiring for entry-level software developers has slowed, and college enrollment in computer science is declining.
College computer science majors are down. AI for everyone else is up
Hiring for entry-level software developers has slowed, and college enrollment in computer science is declining.
Padres Reportedly Turned Down Offer From Yankees For Adrian Morejon
San Diego rebuffed New York’s pursuit of the All-Star southpaw, reportedly declining a deal for Will Warren as the surging Friars reconsider their deadline strategy and roster depth.
Downtown Rochester business owner calls on city to step up and fix sidewalk
A Third Street shop owner is calling on the city to repair uneven pavement near Mayo Clinic after repeated attempts to get a response from local officials were unsuccessful.
Kaiser used an algorithm — not clinicians — to triage mental health patients, union alleges
Union members say they’ve seen no evidence that licensed mental health clinicians review patients’ e-visit answers in real time, or at all.
Low-cost healthcare provider in Tacoma shutters women’s health clinic
An earlier hit affecting a family medicine residency program is blamed in latest action.
A Clinician's Field Guide to Vetting AI Mental Health Tools
A six-question framework for clinicians and patients weighing AI's role in mental health care, from crisis blind spots to shifting state law.
New mental health clinic opens in east Lincoln
A new mental health clinic opened in east Lincoln on Friday.
New mental health clinic opens in east Lincoln
A new mental health clinic opened in east Lincoln on Friday.
Free dental screenings, backpacks offered at local health clinics in Allentown, Bethlehem
Saturday's clinics were for children - hosted at both their downtown Allentown and north side Bethlehem locations.
Panama: Haemophilus influenzae meningitis case reported in Veraguas Health Region
The Veraguas Health Region, located in the central-western region of Panama, confirmed a case of meningitis caused by the Haemophilus influenzae bacteria in a 12-year-old student from La Primavera School, diagnosed on July 29. The patient remains hospitalized, is receiving appropriate treatment, and is in stable clinical condition. The regional health director of Veraguas, Xavier A. Torres Domínguez, reported that, once the diagnosis was confirmed, the Ministry of Health (Minsa), in coordination with the Social Security Fund (CSS), immediately activated the epidemiological investigation and health response protocols established for this type of event. Canada: Haemophilus influenzae type B outbreak in Calgary As part of the actions implemented, the Epidemiology teams carried out the identification and monitoring of the patient’s close contacts, applying the corresponding preventive measures to reduce the risk of transmission and safeguard the health of the educational community. Health authorities explained that meningitis caused by Haemophilus influenzae is a bacterial disease that requires timely medical attention. In that regard, they urged the population to immediately seek medical attention if they experience symptoms such as high fever, severe headache, stiff neck, vomiting, drowsiness, or altered mental status. They also reiterated that vaccination is the main preventive measure against this disease, and therefore called on parents and guardians to verify that their children’s immunization schedules are complete, in accordance with the Expanded Program on Immunization (EPI). Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Healthcare staffing shortages are driving a patient care quality crisis
From hospitals and clinics to doctors' offices and urgent care centers, healthcare executives and clinicians agree: staffing shortages directly compromise their ability to provide high-quality care to patients.
Why alcohol and drug use may be declining among young Americans
New federal data shows that alcohol, cigarette and some drug use is declining among American youth and young adults. Public health specialists explain why.
UFC Belgrade Start Time, Full Fight Card Details
Ultimate Fighting Championship (UFC) is headed to Belgrade, Serbia, for the first time ever TODAY (Sat., Aug. 1, 2026), staging UFC Belgrade from inside Belgrade Arena, streaming live on Paramount+. Headlining the event will be a Welterweight fight between Uros Medic vs. Daniel Rodriguez. In the Light Heavyweight co-main event, former division champion, Jan Błachowicz, […]
PCC sees profits rise, but continues with cuts
"There are some hard choices we have had to make on this ongoing journey," PCC CEO Krish Srinivasan said in a letter to members outlining cuts.
Staying Hydrated as Fall Sports Kick Off
A sports medicine physician highlights the importance of staying hydrated as two-a-days for football and other fall sports kick off this month.
State approves Salem Health-Santiam merger
The Oregon Health Authority has granted a proposed merger between Salem Health and Santiam Hospital & Clinics, state officials said Friday. But the deal can’t close until Oregon Attorney General Dan Rayfield gives his sign off.
'Zombie cells,' inflammation, and other health issue
Dr. Marissa Schaffer with the Mayo Clinic discusses 'zombie cells' and how they cause inflammation and other health issues.
The Streaming Bubble Keeps Popping
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) One of my rules is “never bet against PE [private equity]”. This isn’t to say that I agree with their methods or tactics or strategies or financial innovations (aka shenanigans). Just that in the long arc of financial history, they’ve tended to return very good returns to their shareholders. That said, their forays into entertainment have left me...skeptical. I’ve written before about PE’s production company/celebrity production company roll ups, and those haven’t really worked out. Some PE groups tried to “roll up” an industry that isn’t “roll-up-able” for lack of a better term—since the barrier to entry for starting a production company is very low—often paying top dollar for celebrity production companies at the height of streaming valuations. So yeah maybe we can bet against PE when they venture into filmed entertainment. I’ve also noted that studio lots seemed to be a bubble back in 2022. Sure enough… Yikes! That sure sounds like some private equity guys lost some money. The only caveat being that holding a lot of land in Los Angeles is always valuable. But that wasn’t the pitch and likely real estate investment companies overpaid for said land. I mean, Goldman Sachs had to repossess it after all. (Technically, I’m not sure these buyers were traditional private equity, but PE was buying LA studio lots earlier this decade.) All to say: I call out bubbles when I see them, and they often pop. Anywho, my most famous bubble call was the “streaming bubble”, specifically that the major streamers were making too many shows and films. And that it could all come crashing down. Notably, I made this call before the strikes of 2023, but those strikes potentially accelerated the popping. And now it has indeed popped. One of my most popular articles of last year made that exact case. A year later, it’s time to update that analysis. The bottom line is that the streaming contraction continues. Credit where credit is due, Luminate—an analytics company whose data I use weekly in my streaming ratings report—called this out in a recent report I saw highlighted in both Bloomberg and The Hollywood Reporter. But I’m adding my data to their look, including streaming films and kids TV shows. I’ll also provide some other data that all tells the same picture. Let’s dive in! Subscribe The Number of Streaming TV Shows, Films and Specials Is Declining AGAIN in 2026 Let’s get right to the data, starting with my dataset. Specifically, each week I track every “notable” title to come out on streaming. I try to grab every title on every major streamer, meaning if it’s a first run or original or exclusive, I track it. This helps me call out the “dogs not barking” and the misses/flops each week. So that will be our first series of charts, my weekly collection data. Let’s start with the raw TV show, film and special data, by week. Note: As the years have gone by, I have actually added more sources (going from just one source to five sources) to find new titles, meaning that this data collection is, likely, more accurate now than in the past. Which means my team and I are more likely to have undercounted titles in the past rather than today. I like to cut the data several different ways. Here’s that same look, by quarter, to more sharply show the trends: And here’s the data just looking at the first half of each year. That’s the same data, just cut three different ways with three different time periods. Note that films, TV shows, and specials are all down by 25%, 42% and 17%, respectively, from 2022. The good news is that the number of films and specials actually increased year-over-year from 2025 to 2026, but not enough to offset the 25% decline in TV shows. Now, I also look at kids shows, and here they are pulled out on their own: And here’s that by quarter: This really seems to be a notable area of pullback by the streamers. Kids shows are down 80% from 2022. This reflects some formerly Disney+ shows going to cable TV first, but also pullbacks from HBO Max, Prime Video and Netflix. I also categorize the TV shows by English language and non-English language, and that also reveals a lot of where the drop comes from: And here is by the half-year: In this look, the good news is the drop for English language shows seems to have stabilized in the last year. But the bad news is the long term decline from the 2022 peak. Other Data So I wasn’t the only person to notice this decline in the number of shows. I have a few other data sources for this, though most only go through the end of 2025. As I said, Luminate beat me to the punch, so let’s look at their data. We’re just getting started with this issue, but the rest is for paid subscribers of the Entertainment Strategy Guy, so if you’d like to find out… What TV loss streaming didn’t make up for... How Netflix has changed their programming slate over time… Ten more images charting the decline of production... What type of films aren’t being made anymore... The good news (for movie theaters)… And more... ...please subscribe! We can only keep doing this great work with your support.
Shark Tank, Colossal, Shondaland speakers headlining DFW Startup Week
DFW Startup Week, hosted by the SMU Spears Institute for Entrepreneurial Leadership, is free to attend and will take place from Aug. 3-6.
Global Health program builds future nursing leaders through clinical immersion in Zambia
Students from the UT San Antonio School of Nursing gaining a global perspective on health and cross-cultural care.
Qureight raises $20M to expand AI-powered imaging research platform
The company specializes in providing end-to-end imaging and enterprise services for clinical trials that focus on diseases of the lung and heart.
“Cognitive Spoofing”: How AI Fakes Expertise, And Why It’s A Huge Problem In Healthcare
AI systems have to be pressure-tested in real-world clinical settings to ensure correct reasoning, accuracy and reliability.
Learning from routine health system data builds better neuroimaging AI models
Nature Medicine - We trained a three-dimensional visual foundation model directly on 5.24 million routine clinical computed tomography (CT) and magnetic resonance imaging (MRI) image series so that...
Arkansas Health Department offers back-to-school vaccine clinics, whooping cough focus
GOP Senate nominee ends press conference after questions on ties to White nationalist influencer
Republican Senate candidate Mike Collins ended a press conference Thursday after repeatedly declining to answer questions about his relationship with a son-in-law who promoted White nationalist ideology and circulated antisemitic content online, as first revealed by CNN’s KFile.
Equity and Engagement Partners with University of Illinois to Host Mental Health First Aid Training
Dr. Regina Parnell Clinical Service Manager within the Equity and Engagement Department teamed up this week with the University of Illinois Office of the Vice Chancellor for Student Affairs to host two day long Mental Health First Aid sessions.
New Orlando Health Children’s Pavilion brings several clinics under one roof
Orlando Health has opened a new children's pavilion in Orlando that consolidates 19 pediatric clinics under one roof, aiming to simplify follow-up care and reduce the logistical burden on families managing multiple specialists after a child's hospitalization.
Tanor Bortolini and Charvarius Ward Sr. on team's health, near-retirement decision | 2026 Training camp media availability
Center Tanor Bortolini breaks down how Daniel Jones' return from injury helps the offensive line and the communication the group has with the quarterback. Then, cornerback Charvarius Ward Sr., joined by a special guest, discusses how he was 85% sure he wa
How one kidney care company built a solid AI foundation
Strive Health says its successes with artificial intelligence came from solving for fragmented data, embedding intelligence into clinicians' workflows and keeping providers at the center of care. It's showing up in improved outcomes.